Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 17 March 2026
Accepted: 5 April 2026
First Online: 29 May 2026
Disclosure
: Julie Lang reports serving on the speaker bureau for Merck, receiving a research grant from Flow Pharma, serving on the advisory board for Novartis, and serving as faculty speaker for OncLive. The remaining authors have no conflicts of interest.
